Travere Therapeutics to Present at the 2022 Jefferies Healthcare Conference
Travere Therapeutics (NASDAQ: TVTX) will present at the 2022 Jefferies Healthcare Conference on June 9, 2022, at 10:30 a.m. ET. A live webcast of the presentation will be accessible via their website, with a replay available for 30 days afterward. The company is dedicated to supporting individuals with rare diseases by developing crucial therapies in collaboration with the rare disease community. Travere aims to provide hope and effective treatment options for patients and families worldwide.
- None.
- None.
SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the 2022 Jefferies Healthcare Conference on Thursday, June 9, 2022 at 10:30 a.m. ET.
A live webcast will be available at https://ir.travere.com/events-presentations and an archived replay will be accessible for up to 30 days.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com
Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
IR@travere.com
FAQ
When will Travere Therapeutics present at the Jefferies Healthcare Conference?
How can I access the webcast of Travere Therapeutics' presentation?
What is the focus of Travere Therapeutics?
What is the stock symbol for Travere Therapeutics?
